Haemophilus ducreyi: Clinical disease and pathogenesis

Current Opinion in Infectious Diseases

Volumn 15, Issue 1, 2002, Pages 43-47

  Al Tawfiq, Jaffar A ^a   Spinola, Stanley M ^b  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; HAEMOPHILUS DUCREYI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; ULCUS MOLLE; VIRUS TRANSMISSION;

EID: 0036155269     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200202000-00008     Document Type: Review

References (55)

1. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection
2. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India
3. Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar
4. Genital ulcers: Etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica
5. Human immunodeficiency virus infection and genital ulcer disease in South Africa: The herpetic connection
6. Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi
7. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities
8. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands
9. Chancroid and Haemophilus ducreyi
10. Gross and microscopic features in chancroid: A study in 200 new culture-proven cases in San Salvador
11. Low dose erythromycin regimen for the treatment of chancroid
12. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya
13. Cumulative experience with Haemophilus ducreyi in the human model of experimental infection
14. Diagnostic tests for chancroid
15. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: Association with human immunodeficiency virus infection
16. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers
17. Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid
18. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States
19. Development of a serological test for Haemophilus ducreyi for seroprevatence studies
20. 1998 Guidelines for treatment of sexually transmitted diseases
21. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya
22. Thiamphenicol in the treatment of chancroid, a study of 1,128 cases
23. Ceftriaxone no longer predictably cures chancroid in Kenya
24. On eradicating chancroid
25. Impact of Thailand's HIV control programme as indicated by the decline of sexually transmitted diseases
26. Evidence of declining STD prevalence in a South African mining community following a core-group intervention
27. Prevention of experimental Haemophilus ducreyi infection: A randomized, controlled clinical trial
28. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects
29. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects
30. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection
31. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers
32. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line
33. Characterization of Haemophilus ducreyi-specific T cell lines from lesions of experimentally infected human subjects
34. Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers
35. A DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers
36. An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection
37. Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection
38. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA
39. A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection
40. Evaluation of an isogenic MOMP-deficient mutant in the human model of Haemophilus ducreyi infection
41. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers
42. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of β1,4-glucosyltransferase is virulent in humans
43. Expression of cytolethal distending toxin and hemolysin are not required for pustule formation by Haemophilus ducreyi in human volunteers
44. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated
45. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis
46. Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi
47. Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and β1,4-glucosyltransferase: Identification of LOS glycoforms containing lactosamine repeats
48. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection
49. Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells
50. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi
51. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways
52. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells
53. The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response
54. A novel heme protein, the Cu,Zn-superoxide dismutase from Haemophilus ducreyi